Humedix Co., Ltd. (KOSDAQ:A200670) announced a private placement of series 4 non-guaranteed private equity convertible bonds for gross proceeds of KRW 45,000,000,000 on April 2, 2021. The bonds are issued at 0% nominal interest rate and will mature on April 6, 2026. The bonds can be 100% converted into 1,679,104 common shares for 14.41% stake of the company at a fixed conversion price of KRW 26,800 per share.

The conversion period is from April 6, 2022 to March 6, 2026. The transaction will include participation from Eugene Investment & Securities Co.,Ltd. (KOSE:A001200) for KRW 23,000,000,000, DB Financial Investment Co., Ltd. (KOSE:A016610) for KRW 1,000,000,000, Solon New Technology Association No. 10 for KRW 1,000,000,000, KRW 5,900,000,000 from funds managed by Korea Investment & Securities Co., Ltd., Investment Arm, KRW 4,500,000,000 from funds managed by KB Securities Co., Ltd., Investment Arm, KRW 7,600,000,000 from funds managed by NH Investment & Securities Co., Ltd. (KOSE:A005940), KRW 1,000,000,000 from a fund managed by Korea Investment Partners Co.

Ltd. and KRW 1,000,000,000 from a fund managed by Samsung Securities Co., Ltd. (KOSE:A016360). The transaction has been approved by the board of directors of the company. The subscription date and the payment date is April 6, 2021.